There is a clear need to upskill Houston-area young adults in IT fields, but few programs in Houston have the experience to tackle this issue. Photo courtesy of Genesys Works

Since the start of the pandemic, Texas has emerged as a national leader in job creation. According to a new report from the Pew Research Center, a boom in tech, finance, and professional service employment has helped the state spur 563,000 new jobs since February 2020.

Yet companies across Houston continue to face challenges in identifying and retaining diverse talent to fill their high-growth, high-demand IT positions. Houston IT jobs are projected to increase by 18 percent over the next five years, according to the Gulf Coast Workforce Board, while at the same time, the talent gap in area high school graduates widens.

The lack of diversity in the IT sector has long been acknowledged as an industry-wide challenge. Black and Latinx workers comprise 30 percent of the U.S. labor force but only 16 percent of computing and mathematical occupations, according to the U.S. Bureau of Labor Statistics.

The systematic barriers that prevent diversity in the IT field are vast, and companies often struggle to implement successful inclusion and diversity programs. A report by Capgemini revealed that 85 percent of leadership executives believe their organizations provide equitable opportunities for career development and advancement for all employees, only 18 percent of women and minitories agree.

There is a clear need to upskill Houston-area young adults in IT fields, but few programs in Houston have the experience to tackle this issue.

One local nonprofit is dedicated to addressing this evolving workforce. Genesys Works Houston was created to bridge the gap between companies and motivated, underserved youth 20 years ago. The founders had a simple goal: to create a program that could guide motivated youth into the corporate world where they could get opportunities for meaningful employment. Now, two decades later, the organization has expanded additional chapters across the nation, and serves about 2,500 students each year with internship programs that provide coaching and counseling to high school seniors to find career pathways while helping employers fill critical talent gaps.

The program offers mentorship and coaching during the first six to nine months of employment. Additionally, thanks to a partnership with Workforce Solutions, the program also offers linkages to wraparound services — transportation, basic needs, childcare, etc. — all at no cost to trainees.

The numbers don’t lie — Houston needs to dedicate resources to upskilling its future IT workforce, and supporting organizations like Genesys Works and others can help to bridge that gap.

------

Lis Harper is a strategist and account executive at Houston-based Medley Inc.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.